Esoguard 174 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Esoguard 174. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Esoguard 174 Today - Breaking & Trending Today

PAVmed Receives European CE Mark Certification for its

PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
May 25, 2021 09:30 ET
| Source:
PAVmed Inc.
PAVmed Inc.
NEW YORK, May 25, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has received CE Mark certification for its CarpX
® minimally invasive carpal tunnel device.
EU-based Notified Body TÜV Rhineland LGA Products GMBH issued a CE Certificate, effective May 24, 2021, declaring that CarpX conforms to the essential requirements of Medical Device Directive 93/42/EEC. With CE Mark secured, CarpX may now be marketed in CE Mark European countries, which include the European Economic Area (the EU, Norway, Iceland and Lichtenstein), Switzerland, and, until July 1, 2023, the United Kingdom. ....

United Kingdom , Jim Heins Katie Gallagher , Shaun Oneil , Mark Carp , Matt Ennis , Lishan Aklog , Mike Havrilla , Its Gi Health , Lucid Diagnostics Inc , Drug Administration , Exchange Commission , Pavmed Inc , Globe Newswire Pavmed Inc , Medical Device Directive , European Economic Area , Chief Executive , Esophageal Cell Collection , Esophageal Ablation Device , Its Minimally Invasive Interventions , Minimally Invasive Device , Carpal Tunnel , Infusion Therapy , Implantable Intraosseous Vascular Access Device , Intravenous Infusion Set , Emerging Innovations , Seriesw Warrants ,

PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

NEW YORK, March 10, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer will present a corporate update at the
Inaugural Emerging Growth Virtual Conference, held by M Vest LLC and Maxim Group LLC. The conference will take place on March 17th - 19th from 9:00 AM to 5:00 PM EDT.
During this virtual conference, the Company will present along with other important voices in the healthcare sector. The conference will feature roundtable discussions, issuer presentations, fireside chats, and live Q&A with company CEOs moderated by Maxim research analysts. To attend and access conference content, sign up to become an M-Vest member for more updates HERE. ....

New York , United States , Beth Amorosi , Shaun Oneil , Katie Gallagher , Lishan Aklog , Mike Havrilla , Lucid Diagnostics Inc , Gi Health Esoguard , Exchange Commission , Maxim Group , M Vest , Pavmed Inc , Globe Newswire Pavmed Inc , Chief Executive Officer , Inaugural Emerging Growth Virtual Conference , New York City , Municipal Securities Rulemaking Board , Esophageal Cell Collection Device , Esophageal Ablation Device , Minimally Invasive Interventions , Minimally Invasive Device , Carpal Tunnel Syndrome , Infusion Therapy , Implantable Intraosseus Vascular Access Device , Emerging Innovations ,